Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
Sponsor: Brigham and Women's Hospital
Summary
The investigators will perform a phase 2a, randomized, double-blind, placebo-controlled clinical trial in adult patients undergoing elective coronary artery bypass grafting (CABG) surgery to investigate the effects of oral nicotinamide mononucleotide (NMN) administration on myocardial NAD+ concentrations and on postoperative markers of myocardial and kidney injury.
Official title: Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-03-31
Completion Date
2029-01-01
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Interventions
MIB-626
An orally-administered stable crystalline tablet formulation of NMN
Placebo
matching placebo tablets
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States